{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:59:39Z","timestamp":1793059179088,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:p>In this study we evaluated the cardiac effects of a pharmaceutical formulation developed by including angiotensin (Ang)-(1-7) in hydroxypropyl \u03b2-cyclodextrin (HP\u03b2CD), in normal, infarcted, and isoproterenol-treated rats. Myocardial infarction was produced by left coronary artery occlusion. Isoproterenol (2 mg\/kg, IP) was administered daily for 7 days. Oral administration of HP\u03b2CD\/Ang-(1-7) started immediately before infarction or associated with the first dose of isoproterenol. After 7 days of treatment, the rats were euthanized, and the Langendorff technique was used to analyze cardiac function. In addition, heart function was chronically (15, 30, 50 days) analyzed by echocardiography. Cardiac sections were stained with hematoxylin\/eosin and Masson trichrome to evaluate cardiac hypertrophy and damage, respectively. Pharmacokinetic studies showed that oral HP\u03b2CD\/Ang-(1-7) administration significantly increased Ang-(1-7) on plasma whereas with the free peptide it was without effect. Oral administration of HP\u03b2CD\/Ang-(1-7) (30 \u03bcg\/kg) significantly reduced the deleterious effects induced by myocardial infarction on systolic and diastolic tension, \u00b1dT\/dt, perfusion pressure, and heart rate. Strikingly, a 50% reduction of the infarcted area was observed in HP\u03b2CD\/Ang-(1-7)\u2013treated rats. Furthermore, HP\u03b2CD\/Ang-(1-7) attenuated the heart function impairment and cardiac remodeling induced by isoproterenol. In infarcted rats chronically treated with HP\u03b2CD\/Ang-(1-7), the reduction of ejection fraction and fractional shorting and the increase in systolic and diastolic left ventricular volumes observed in infarcted rats were attenuated. Altogether, these findings further confirm the cardioprotective effects of Ang-(1-7). More importantly, our data indicate that the HP\u03b2CD\/Ang-(1-7) is a feasible formulation for oral administration of Ang-(1-7), which can be used as a cardioprotective drug.<\/jats:p>","DOI":"10.1161\/hypertensionaha.110.167346","type":"journal-article","created":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T03:52:11Z","timestamp":1296532331000},"page":"477-483","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":124,"title":["An Oral Formulation of Angiotensin-(1-7) Produces Cardioprotective Effects in Infarcted and Isoproterenol-Treated Rats"],"prefix":"10.1161","volume":"57","author":[{"given":"F\u00falvia D.","family":"Marques","sequence":"first","affiliation":[{"name":"From the National Institute of Science and Technology in Nanobiopharmaceutics (F.D.M., R.D.M.S., F.B.S., M.B.M., A.P.N., L.E.S., M.C.C.I., R.A.S.S.) and Departments of Physiology and Biophysics (F.D.M., A.P.A., R.A.S.S.), Morphology (F.D.M., A.J.F., B.A.J., G.A.B.S.), and General Pathology (M.V.C.), Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Rio Grande do Sul Cardiology Institute (M.C.C.I., R.A.S.S.), University Cardiology Foundation, Porto Alegre, Rio Grande do Sul,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson J.","family":"Ferreira","sequence":"additional","affiliation":[{"name":"From the National Institute of Science and Technology in Nanobiopharmaceutics (F.D.M., R.D.M.S., F.B.S., M.B.M., A.P.N., L.E.S., M.C.C.I., R.A.S.S.) and Departments of Physiology and Biophysics (F.D.M., A.P.A., R.A.S.S.), Morphology (F.D.M., A.J.F., B.A.J., G.A.B.S.), and General Pathology (M.V.C.), Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Rio Grande do Sul Cardiology Institute (M.C.C.I., R.A.S.S.), University Cardiology Foundation, Porto Alegre, Rio Grande do Sul,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n D.M.","family":"Sinisterra","sequence":"additional","affiliation":[{"name":"From the National Institute of Science and Technology in Nanobiopharmaceutics (F.D.M., R.D.M.S., F.B.S., M.B.M., A.P.N., L.E.S., M.C.C.I., R.A.S.S.) and Departments of Physiology and Biophysics (F.D.M., A.P.A., R.A.S.S.), Morphology (F.D.M., A.J.F., B.A.J., G.A.B.S.), and General Pathology (M.V.C.), Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Rio Grande do Sul Cardiology Institute (M.C.C.I., R.A.S.S.), University Cardiology Foundation, Porto Alegre, Rio Grande do Sul,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno A.","family":"Jacoby","sequence":"additional","affiliation":[{"name":"From the National Institute of Science and Technology in Nanobiopharmaceutics (F.D.M., R.D.M.S., F.B.S., M.B.M., A.P.N., L.E.S., M.C.C.I., R.A.S.S.) and Departments of Physiology and Biophysics (F.D.M., A.P.A., R.A.S.S.), Morphology (F.D.M., A.J.F., B.A.J., G.A.B.S.), and General Pathology (M.V.C.), Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Rio Grande do Sul Cardiology Institute (M.C.C.I., R.A.S.S.), University Cardiology Foundation, Porto Alegre, Rio Grande do Sul,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico B.","family":"Sousa","sequence":"additional","affiliation":[{"name":"From the National Institute of Science and Technology in Nanobiopharmaceutics (F.D.M., R.D.M.S., F.B.S., M.B.M., A.P.N., L.E.S., M.C.C.I., R.A.S.S.) and Departments of Physiology and Biophysics (F.D.M., A.P.A., R.A.S.S.), Morphology (F.D.M., A.J.F., B.A.J., G.A.B.S.), and General Pathology (M.V.C.), Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Rio Grande do Sul Cardiology Institute (M.C.C.I., R.A.S.S.), University Cardiology Foundation, Porto Alegre, Rio Grande do Sul,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo V.","family":"Caliari","sequence":"additional","affiliation":[{"name":"From the National Institute of Science and Technology in Nanobiopharmaceutics (F.D.M., R.D.M.S., F.B.S., M.B.M., A.P.N., L.E.S., M.C.C.I., R.A.S.S.) and Departments of Physiology and Biophysics (F.D.M., A.P.A., R.A.S.S.), Morphology (F.D.M., A.J.F., B.A.J., G.A.B.S.), and General Pathology (M.V.C.), Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Rio Grande do Sul Cardiology Institute (M.C.C.I., R.A.S.S.), University Cardiology Foundation, Porto Alegre, Rio Grande do Sul,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerluza A.B.","family":"Silva","sequence":"additional","affiliation":[{"name":"From the National Institute of Science and Technology in Nanobiopharmaceutics (F.D.M., R.D.M.S., F.B.S., M.B.M., A.P.N., L.E.S., M.C.C.I., R.A.S.S.) and Departments of Physiology and Biophysics (F.D.M., A.P.A., R.A.S.S.), Morphology (F.D.M., A.J.F., B.A.J., G.A.B.S.), and General Pathology (M.V.C.), Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Rio Grande do Sul Cardiology Institute (M.C.C.I., R.A.S.S.), University Cardiology Foundation, Porto Alegre, Rio Grande do Sul,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos B.","family":"Melo","sequence":"additional","affiliation":[{"name":"From the National Institute of Science and Technology in Nanobiopharmaceutics (F.D.M., R.D.M.S., F.B.S., M.B.M., A.P.N., L.E.S., M.C.C.I., R.A.S.S.) and Departments of Physiology and Biophysics (F.D.M., A.P.A., R.A.S.S.), Morphology (F.D.M., A.J.F., B.A.J., G.A.B.S.), and General Pathology (M.V.C.), Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Rio Grande do Sul Cardiology Institute (M.C.C.I., R.A.S.S.), University Cardiology Foundation, Porto Alegre, Rio Grande do Sul,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana P.","family":"Nadu","sequence":"additional","affiliation":[{"name":"From the National Institute of Science and Technology in Nanobiopharmaceutics (F.D.M., R.D.M.S., F.B.S., M.B.M., A.P.N., L.E.S., M.C.C.I., R.A.S.S.) and Departments of Physiology and Biophysics (F.D.M., A.P.A., R.A.S.S.), Morphology (F.D.M., A.J.F., B.A.J., G.A.B.S.), and General Pathology (M.V.C.), Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Rio Grande do Sul Cardiology Institute (M.C.C.I., R.A.S.S.), University Cardiology Foundation, Porto Alegre, Rio Grande do Sul,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro E.","family":"Souza","sequence":"additional","affiliation":[{"name":"From the National Institute of Science and Technology in Nanobiopharmaceutics (F.D.M., R.D.M.S., F.B.S., M.B.M., A.P.N., L.E.S., M.C.C.I., R.A.S.S.) and Departments of Physiology and Biophysics (F.D.M., A.P.A., R.A.S.S.), Morphology (F.D.M., A.J.F., B.A.J., G.A.B.S.), and General Pathology (M.V.C.), Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Rio Grande do Sul Cardiology Institute (M.C.C.I., R.A.S.S.), University Cardiology Foundation, Porto Alegre, Rio Grande do Sul,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.C.","family":"Irigoyen","sequence":"additional","affiliation":[{"name":"From the National Institute of Science and Technology in Nanobiopharmaceutics (F.D.M., R.D.M.S., F.B.S., M.B.M., A.P.N., L.E.S., M.C.C.I., R.A.S.S.) and Departments of Physiology and Biophysics (F.D.M., A.P.A., R.A.S.S.), Morphology (F.D.M., A.J.F., B.A.J., G.A.B.S.), and General Pathology (M.V.C.), Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Rio Grande do Sul Cardiology Institute (M.C.C.I., R.A.S.S.), University Cardiology Foundation, Porto Alegre, Rio Grande do Sul,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvair P.","family":"Almeida","sequence":"additional","affiliation":[{"name":"From the National Institute of Science and Technology in Nanobiopharmaceutics (F.D.M., R.D.M.S., F.B.S., M.B.M., A.P.N., L.E.S., M.C.C.I., R.A.S.S.) and Departments of Physiology and Biophysics (F.D.M., A.P.A., R.A.S.S.), Morphology (F.D.M., A.J.F., B.A.J., G.A.B.S.), and General Pathology (M.V.C.), Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Rio Grande do Sul Cardiology Institute (M.C.C.I., R.A.S.S.), University Cardiology Foundation, Porto Alegre, Rio Grande do Sul,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson A.S.","family":"Santos","sequence":"additional","affiliation":[{"name":"From the National Institute of Science and Technology in Nanobiopharmaceutics (F.D.M., R.D.M.S., F.B.S., M.B.M., A.P.N., L.E.S., M.C.C.I., R.A.S.S.) and Departments of Physiology and Biophysics (F.D.M., A.P.A., R.A.S.S.), Morphology (F.D.M., A.J.F., B.A.J., G.A.B.S.), and General Pathology (M.V.C.), Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Rio Grande do Sul Cardiology Institute (M.C.C.I., R.A.S.S.), University Cardiology Foundation, Porto Alegre, Rio Grande do Sul,..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.34.2.296"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2006.09.006"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2000000600012"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.26.6.1154"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000143850.73831.9d"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00632.2005"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.38.3.665"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2002000900009"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000013847.07035.b9"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01170.2005"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00937.2006"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00317.2005"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00941.2004"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.2007.041830"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000251865.35728.2f"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1432869100"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20040634"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000037979.53963.8f"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.107.108944"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.2006.00239.x"},{"key":"e_1_3_3_22_2","first-page":"H1113","article-title":"The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE 0991 attenuates heart failure induced by myocardial infarction","volume":"29","author":"Ferreira AJ","year":"2007","unstructured":"Ferreira AJ, Jacoby BA, Ara\u00fajo CAA, Macedo FAFF, Silva GAB, Almeida AP, Caliari MV, Santos RAS. The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE 0991 attenuates heart failure induced by myocardial infarction. Am J Physiol. 2007;29:H1113\u2013H1119.","journal-title":"Am J Physiol"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2007.07.022"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2007.08.011"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(94)90103-1"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00227.2003"},{"key":"e_1_3_3_27_2","first-page":"H313","article-title":"Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats","volume":"269","author":"Benter IF","year":"1995","unstructured":"Benter IF, Ferrario CM, Morris M, Diz DI. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol. 1995;269:H313\u2013H319.","journal-title":"Am J Physiol"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00618.2005"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.34.4.950"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(01)00720-7"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2004.07.023"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.110.167346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:28:16Z","timestamp":1715592496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.110.167346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.110.167346"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.110.167346","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"2010-11-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-01-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-01-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}